HLN vs PBH vs KVUE vs CHD vs PG

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Prestige Consumer Healthcare Inc. (PBH) offers the better valuation at 12. 2x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Prestige Consumer Healthcare Inc.

(PBH) is the cheapest at 12. 2x versus Church & Dwight Co. , Inc. at 30. 9x. On forward P/E, Prestige Consumer Healthcare Inc. is actually cheaper at 11. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Prestige Consumer Healthcare Inc. wins at 1. 28x versus The Procter & Gamble Company's 3. 80x — a reasonable growth-adjusted valuation.

Over the past 5 years, Haleon plc (HLN) delivered a total return of +29.

0%, compared to -26. 3% for Kenvue Inc. (KVUE). Over 10 years, the gap is even starker: PG returned +119. 7% versus KVUE's -26. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.

03β versus Prestige Consumer Healthcare Inc. 's 0. 43β — meaning PBH is approximately 1403% more volatile than HLN relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 79% for Kenvue Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Kenvue Inc. grew EPS 40. 7% year-over-year, compared to 2. 9% for Prestige Consumer Healthcare Inc.. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Procter & Gamble Company (PG) is the more profitable company, earning 19.

0% net margin versus 9. 7% for Kenvue Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 17. 4% for CHD. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Prestige Consumer Healthcare Inc. (PBH) is the more undervalued stock at a PEG of 1. 28x versus The Procter & Gamble Company's 3. 80x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Prestige Consumer Healthcare Inc. (PBH) trades at 11. 6x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 13. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PBH: 25. 6% to $66. 00.

In this comparison, KVUE (4.

7% yield), PG (2. 7% yield), HLN (2. 0% yield), CHD (1. 3% yield) pay a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Haleon plc (HLN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

03), 2. 0% yield). Both have compounded well over 10 years (HLN: +29. 0%, PBH: -7. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HLN (Healthcare) and PBH (Healthcare) and KVUE (Consumer Defensive) and CHD (Consumer Defensive) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLN is a mid-cap quality compounder stock; PBH is a small-cap deep-value stock; KVUE is a mid-cap income-oriented stock; CHD is a mid-cap quality compounder stock; PG is a large-cap quality compounder stock. HLN, KVUE, CHD, PG pay a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.